Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer
Codony-Servat, Jordi; Cuatrecasas, Miriam; Asensio, Elena; Montironi, Carla; Martínez Cardús, Anna; Marín Aguilera, Mercedes; Horndler, Carlos; Martínez Balibrea, Eva; Rubini, Michele; Jares, Pedro; Reig, Oscar; Victoria, Iván; Gaba, Lydia; Martín Richard, Marta; Alonso, Vicente; Escudero, Pilar; Fernández-Martos, Carlos; Feliu, Jaime; Méndez, Jose Carlos; Méndez, Miguel; Gallego, Javier; Salud, Antonieta; Rojo, Federico; Castells, Antoni; Prat, Aleix; Rosell, Rafael; García-Albéniz, Xabier; Camps, Jordi; Maurel, Joan; Universitat Autònoma de Barcelona
Altres ajuts: Mutua Madrileña (AP75002010); Porgrama CERCA; CIBERehd
Although chemotherapy is the cornerstone treatment for patients with metastatic colorectal cancer (mCRC), acquired chemoresistance is common and constitutes the main reason for treatment failure. Monoclonal antibodies against insulin-like growth factor-1 receptor (IGF-1R) have been tested in pre-treated mCRC patients, but results have been largely deceiving. We analysed time to progression, overall survival, and the mutational status of RAS, BRAF and nuclear p-IGF-1R expression by immunohistochemistry, in 470 metastatic CRC patients. The effect of IGF-1R activation and distribution was also assessed using cellular models of CRC and RNAi for functional validation. Nuclear IGF-1R increased in metastatic tumours compared to paired untreated primary tumours, and significantly correlated with poor overall survival in mCRC patients. In vitro, chemo-resistant cell lines presented significantly higher levels of IGF-1R expression within the nuclear compartment, and PIAS3, a protein implicated also in the sumoylation process of intranuclear proteins, contributed to IGF-1R nuclear sequestration, highlighting the essential role of PIAS3 in this process. Intriguingly, we observed that ganitumab, an IGF-1R blocking-antibody used in several clinical trials, and dasatinib, an SRC inhibitor, increased the nuclear localisation of IGF-1R. Our study demonstrates that IGF-1R nuclear location might lead to chemotherapy and targeted agent resistance.
-IGF-1R
-Nuclear internalisation
-Acquired resistance
-Colorectal cancer
-BRAF mutation
open access
Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra, i la creació d'obres derivades, sempre que no sigui amb finalitats comercials i que es distribueixin sota la mateixa llicència que regula l'obra original. Cal que es reconegui l'autoria de l'obra original.
https://creativecommons.org/licenses/by-nc-sa/4.0/
Article
         
https://ddd.uab.cat/record/200564

Mostra el registre complet del document

Documents relacionats

Altres documents del mateix autor/a

Alonso, Vicente; Escudero, Pilar; Fernández-Martos, Carlos; Salud Salvia, Maria Antonieta; Méndez, Miguel; Gallego, Javier; Rodriguez, Jose-R.; Martín-Richard, Marta; Fernández-Plana, Julen; Manzano, Hermini; Méndez, José-Carlos; Zanui, Monserrat; Falcó, Esther; Gil-Raga, Mireia; Rojo, Federico; Cuatrecasas, Miriam; Feliu, Jaime; García-Albéniz, Xabier; Maurel, Joan
Marín Aguilera, Mercedes; Reig, Oscar; Lozano Salvatella, Juan José; Jiménez, Natalia; Garcia Recio, Susana; Erill, Nadina; Gaba, Lydia; Tagliapietra, Andrea; Ortega, Vanessa; Carrera, Gemma; Colomer, Anna; Gascón, Pere; Mellado González, Begoña
Marín Aguilera, Mercedes; Reig, Oscar; Lozano Salvatella, Juan José; Jiménez, Natalia; Garcia Recio, Susana; Erill, Nadina; Gaba, Lydia; Tagliapietra, Andrea; Ortega, Vanessa; Carrera, Gemma; Colomer, Anna; Gascón, Pere; Mellado González, Begoña
Salazar Soler, Ramón; Capdevila, Jaume; Laquente, Berta; Manzano, Jose Luis; Pericay, Carles; Martínez Villacampa, Mercedes; López López, Carlos; Losa Gaspà, Ferran; Safont, Maria Jose; Gómez, Auxiliadora; Alonso, Vicente; Escudero, Pilar; Gallego, Javier; Sastre, Javier; Grávalos, Cristina; Biondo, Sebastián; Palacios, Amalia; Aranda, Enrique
Trilla-Fuertes, Lucía; Gámez-Pozo, Angelo; Maurel, Joan; García-Carbonero, Rocío; Capdevila Castillón, Jaume; G-Pastrián, Laura; Mendiola, Marta; Peña, Cristina; López-Vacas, Rocío; Cuatrecasas, Miriam; García-Alfonso, Pilar; Ramos-Ruiz, Ricardo; Llorens, Carlos; Ghanem, Ismael; Conill, Carles; Heredia Soto, Victoria; Campos-Barros, Ángel; Fresno Vara, Juan Ángel; Feliu, Jaime; Universitat Autònoma de Barcelona